- Home
- EVOK vs TTNP Comparison
EVOK vs TTNP Comparison
Compare EVOK & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- TTNP
- Stock Information
- Founded
- EVOK 2007
- TTNP 1991
- Country
- EVOK United States
- TTNP United States
- Employees
- EVOK N/A
- TTNP N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVOK Health Care
- TTNP Health Care
- Exchange
- EVOK Nasdaq
- TTNP Nasdaq
- Market Cap
- EVOK 5.4M
- TTNP 5.4M
- IPO Year
- EVOK 2013
- TTNP 1996
- Fundamental
- Price
- EVOK $5.12
- TTNP $4.93
- Analyst Decision
- EVOK
- TTNP
- Analyst Count
- EVOK 0
- TTNP 0
- Target Price
- EVOK N/A
- TTNP N/A
- AVG Volume (30 Days)
- EVOK 104.5K
- TTNP 49.3K
- Earning Date
- EVOK 08-14-2025
- TTNP 08-26-2025
- Dividend Yield
- EVOK N/A
- TTNP N/A
- EPS Growth
- EVOK N/A
- TTNP N/A
- EPS
- EVOK N/A
- TTNP N/A
- Revenue
- EVOK $12,794,859.00
- TTNP N/A
- Revenue This Year
- EVOK $57.82
- TTNP N/A
- Revenue Next Year
- EVOK $59.12
- TTNP N/A
- P/E Ratio
- EVOK N/A
- TTNP N/A
- Revenue Growth
- EVOK 70.02
- TTNP N/A
- 52 Week Low
- EVOK $1.94
- TTNP $3.03
- 52 Week High
- EVOK $12.32
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- EVOK 55.77
- TTNP 62.92
- Support Level
- EVOK $4.61
- TTNP $4.64
- Resistance Level
- EVOK $5.70
- TTNP $5.17
- Average True Range (ATR)
- EVOK 0.52
- TTNP 0.29
- MACD
- EVOK -0.03
- TTNP 0.11
- Stochastic Oscillator
- EVOK 71.01
- TTNP 83.67
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.